Transcranial Direct Current Stimulation (tDCS) for Treatment-Resistant Obsessive-Compulsive Disorder (FRONT)

Not Applicable

Completed

Interventions: Device: Active tDCS (transcranial direct current stimulation)
Device: Sham tDCS

Brief Summary: Neuromodulation techniques for the treatment of Obsessive-Compulsive Disorder (OCD) have expanded with the greater understanding of the brain circuits involved in this disorder. Transcranial direct current stimulation (tDCS) is a non-invasive neuromodulation technique that has been studied as an alternative for strategy for treatment-resistant OCD. The main study is a randomized, sham-controlled, double-blinded trial tDCS for OCD patients unresponsive to cognitive-behavioral therapy and/or selective serotonin reuptake inhibitors. Forty-four patients will be randomized to two groups: active or simulated intervention. The intervention consisted of delivering an electric current of 2mA to the cathode, positioned bilaterally in the cranial region corresponding to the supplementary motor cortex, and the anode positioned in the deltoid (neutral region), during 30-minutes, for four consecutive weeks. The primary outcome was the reduction in baseline YBOCS scores before and after of tDCS treatment. Secondary outcomes include measures of depressive and anxiety symptoms, genetic markers, motor cortical excitability and performance in neurocognitive tests.

Recruitment & Eligibility

Inclusion Criteria

Patients diagnosed with OCD according to DSM IV criteria
YBOCS score of 16 and above or ≥10 (for the presence of only compulsions or only obsessions)
Patients with other psychiatric comorbidities are not excluded, however, OCD should be the most important disease .
Age between 18 and 65
Patients who failed one or more treatments
Patients with no previous treatment for OCD will be treated with one first line treatment before being considered to participate in the tDCS trial.
Voluntary and competent to consent

Exclusion Criteria

Other diagnostic axis I whose treatment take precedence over the treatment of OCD (bipolar affective disorder; dependence alcohol; schizophrenia or psychotic disorders; dementia)
Presence of other neurological diseases or severe clinical as neurodegenerative diseases, severe aphasia, malignancies activity, epilepsy, previous head injury, congestive heart failure or chronic obstructive pulmonary disease stage III or IV;
Presence of severe suicidal ideation (Structured planning suicide or attempted suicide in the past 4 weeks);
Pregnancy;
Inability to provide informed consent;
Specific contraindication to tDCS: ( metal plates on the head, anatomic changes.);
In relation to the current use of psychotropic drugs will be permitted, provided they are in doses stable for at least 6 weeks.

Arm && Interventions

Group	Intervention	Description
Active tDCS	Active tDCS (transcranial direct current stimulation)	Electric current of 2mA delivered to the cathode, positioned bilaterally in the cranial region corresponding to the supplementary motor cortex, with the anode positioned in the deltoid (neutral region), in 30-minute sessions, 5 days a week (Mondays through Fridays) for four consecutive weeks.
Sham tDCS	Sham tDCS	In this group, the cathode is positioned bilaterally in the cranial region corresponding to the supplementary motor cortex, with the anode positioned in the deltoid (neutral region), in 30-minute sessions, 5 days a week (Mondays through Fridays) for four consecutive weeks, without delivery of the electric current.

Primary Outcome Measures

Name	Time	Method
change in baseline Yale-Brown Obsessive Compulsive Scale score	weeks 4,6,9,12

Secondary Outcome Measures

Name	Time	Method
Beck Depression Inventory symptoms,	baseline, weeks 6 and 12
Beck Anxiety Inventory	baseline, week 6 and 12
Global Clinical Impression Scale - improvement	baseline, week 6 and 12

Receive instant email notifications about changes in this clinical trial

Receive instant email notifications about changes in this clinical trial